Skip to Content

APO MYC500 (Mycophenolate Mofetil 500 mg)

Pill with imprint APO MYC500 is Purple, Capsule-shape and has been identified as Mycophenolate Mofetil 500 mg. It is supplied by Apotex Corp..

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; autoimmune hepatitis; bullous pemphigoid; organ transplant, rejection prophylaxis; graft-versus-host disease (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO MYC500

Mycophenolate Mofetil

Imprint:
APO MYC500
Strength:
500 mg
Color:
Purple
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Apotex Corp.
Inactive Ingredients:
croscarmellose sodium
magnesium stearate
ferric oxide red
titanium dioxide
ferrosoferric oxide
microcrystalline cellulose
silicon dioxide
hypromelloses
hydroxypropyl cellulose
propylene glycol
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0588 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide